Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HSPA8 Single-Nucleotide Polymorphism Is Associated with Serum HSC70 Concentration and Carotid Artery Atherosclerosis in Nonalcoholic Fatty Liver Disease.
Zhao W, Mori H, Tomiga Y, Tanaka K, Perveen R, Mine K, Inadomi C, Yoshioka W, Kubotsu Y, Isoda H, Kuwashiro T, Oeda S, Akiyama T, Zhao Y, Ozaki I, Nagafuchi S, Kawaguchi A, Aishima S, Anzai K, Takahashi H. Zhao W, et al. Among authors: takahashi h. Genes (Basel). 2022 Jul 16;13(7):1265. doi: 10.3390/genes13071265. Genes (Basel). 2022. PMID: 35886046 Free PMC article.
Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Oza N, Nakashita S, Hara M, Iwane S, Takahashi H, Akiyama T, Ario K, Kawaguchi Y, Yasutake T, Iwakiri R, Ozaki I, Hisatomi A, Eguchi T, Ono N, Fujimoto K. Eguchi Y, et al. Among authors: takahashi h. Liver Int. 2009 Feb;29(2):213-20. doi: 10.1111/j.1478-3231.2008.01853.x. Epub 2008 Aug 14. Liver Int. 2009. PMID: 18710430
Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load.
Mizuta T, Kawaguchi Y, Eguchi Y, Takahashi H, Ario K, Akiyama T, Oza N, Otsuka T, Kuwashiro T, Yoshimura T, Hisatomi A, Ozaki I. Mizuta T, et al. Among authors: takahashi h. Dig Dis Sci. 2010 Jan;55(1):183-9. doi: 10.1007/s10620-008-0691-2. Epub 2009 Jan 30. Dig Dis Sci. 2010. PMID: 19184426
A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff.
Oza N, Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Horie H, Ushirogawa M, Tsuzura T, Nakashita S, Takahashi H, Kawaguchi Y, Oda Y, Iwakiri R, Ozaki I, Eguchi T, Ono N, Fujimoto K. Oza N, et al. Among authors: takahashi h. J Gastroenterol. 2009;44(12):1203-8. doi: 10.1007/s00535-009-0115-x. Epub 2009 Sep 1. J Gastroenterol. 2009. PMID: 19728009
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.
Eguchi Y, Mizuta T, Sumida Y, Ishibashi E, Kitajima Y, Isoda H, Horie H, Tashiro T, Iwamoto E, Takahashi H, Kuwashiro T, Soejima S, Kawaguchi Y, Oda Y, Emura S, Iwakiri R, Ozaki I, Eguchi T, Ono N, Anzai K, Fujimoto K, Koizumi S. Eguchi Y, et al. Among authors: takahashi h. J Gastroenterol. 2011 Jan;46 Suppl 1:70-8. doi: 10.1007/s00535-010-0340-3. Epub 2010 Nov 2. J Gastroenterol. 2011. PMID: 21042922
14,165 results
You have reached the last available page of results. Please see the User Guide for more information.